Monitoring ICS underuse in asthma and over-reliance on SABA: A sponsored supplement. Improving outcomes in asthma as an inflammatory disease: spotlight on monitoring ICS underuse and over-reliance on SABA: A sponsored supplement. A report of a multi-disciplinary consensus meeting held in December 2018. AstraZeneca organised and fully funded the meeting and the production of this supplement. All meeting participants reviewed and commented upon the content of this supplement. The views expressed are not necessarily those of AstraZeneca or PCRS.
The asthma slide rule helps to start a conversation with your patients and/or colleagues around how much salbutamol is acceptable before a review is necessary
The RSF helps those looking to design a patient focussed respiratory service working across all sectors of out of hospital care
Primary Care Respiratory Update produces a regular feature article where we explore how healthcare professionals can support self-management in a range of conditions. These include:-
You may also be interested in...
Asthma Right Care (ARC) is a global social movement created by the International Primary Care Respiratory Group (IPCRG) to drive change and disrupt the status quo in asthma management. Here you'll find podcasts, webinars, practical guidance and patient tools to help improve asthma outcomes.
The mMRC (Modified Medical Research Council) Dyspnoea Scale is used to assess the degree of baseline functional disability due to dyspnoea.
The PCRS Greener Respiratory Healthcare Quality Improvement (QI) toolkit has been developed to support HCPs working in the primary care setting to understand and evaluate the environmental impact of their clinical practice, identify ways to reduce this impact, set goals and priorities and evaluat
Self-reported during community pharmacy consultations in London